ResearcherQingdao UniversityActive in the last 2 years
Junjin Wang
Matched on ORCID iD 0000-0002-5676-7062; OpenAlex author ID A5064403487. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 3 papers
Papers 5
- Mitochondrial Calcium Uniporter Drives Chemoresistance in Pancreatic Cancer via Glutathione-Mediated Stemness Maintenance. Co-author DOI 10.1002/advs.202507346↗
- EGFR-Targeting IgG1 Antibody Enhances NK Cell-Mediated Tumor Killing in KRAS-Mutant Pancreatic Cancer. Co-author DOI 10.1002/mco2.70860↗
- Cancer cell-specific FOXP3 licenses MMP19-dependent matrix remodeling and metastatic dissemination in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-026-04025-y↗
- Nomogram model for predicting early recurrence for resectable pancreatic cancer: A multicenter study. Co-author DOI 10.1097/md.0000000000037440↗
- Crosstalk Between Peripheral Innervation and Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1007/s12264-023-01082-1↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiuchao Wang · 3 shared papers, 2023–2026 · strength 0.77
- Paper Cancer cell-specific FOXP3 licenses MMP19-dependent matrix remodeling and metastatic dissemination in pancreatic ductal… DOI 10.1038/s41388-026-04025-y↗
- Paper Mitochondrial Calcium Uniporter Drives Chemoresistance in Pancreatic Cancer via Glutathione-Mediated Stemness Maintenan… DOI 10.1002/advs.202507346↗
- Paper Crosstalk Between Peripheral Innervation and Pancreatic Ductal Adenocarcinoma. DOI 10.1007/s12264-023-01082-1↗
- Ruining Gong · 2 shared papers, 2026 · strength 0.59
- He Ren · 2 shared papers, 2026 · strength 0.59
- Ruoxi Xiao · 1 shared paper, 2026 · strength 0.28
- Ke Lei · 1 shared paper, 2026 · strength 0.28
- Quan Man · 1 shared paper, 2024 · strength 0.26
- Song Gao · 1 shared paper, 2024 · strength 0.26
- Yuexiang Liang · 1 shared paper, 2024 · strength 0.26
- Shaofei Chang · 1 shared paper, 2024 · strength 0.26
- Shengyu Yang · 1 shared paper, 2026 · strength 0.24
- Yunzhan Li · 1 shared paper, 2026 · strength 0.24
- Zekun Li · 1 shared paper, 2026 · strength 0.24
- Xiaofan Guo · 1 shared paper, 2026 · strength 0.24
- Chao Xu · 1 shared paper, 2026 · strength 0.24
- Yongjie Xie · 1 shared paper, 2026 · strength 0.24
- Tianxing Zhou · 1 shared paper, 2026 · strength 0.24
- Jihui Hao · 1 shared paper, 2026 · strength 0.24
- Kaiyuan Wang · 1 shared paper, 2023 · strength 0.22
- Bo Ni · 1 shared paper, 2023 · strength 0.22
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.